Antigen Sensitization

Preferred Label : Antigen Sensitization;

NCIt definition : Antigen Sensitization is a process of immunization with an antigen preparation that renders an immune-response involving generation of antibodies against the specific antigen(s) injected.;

Details

Origin ID

C45548;

UMLS CUI

C1706823;

Semantic type(s)
- Molecular Function [UMLS semantic type]
biological_process_has_associated_location
- Antigen Presenting Cell [NCIt concept]
biological_process_has_initiator_chemical_or_drug
- Antigen [NCIt concept]
biological_process_is_part_of_process
- Immunity [NCIt concept]
is_mechanism_of_action_of_chemical_or_drug
- (H115D)VHL35 Peptide [NCIt concept]
- 117-126:FGF-5 Peptide [NCIt concept]
- 12 Melanoma Peptide Vaccine [NCIt concept]
- 27-35(27L):MART-1 Peptide [NCIt concept]
- 2G-1 TCR Retroviral Vector-Transduced Lymphocytes [NCIt concept]
- 4H11-28z/fIL-12/EGFRt-expressing Autologous T-lymphocytes [NCIt concept]
- 851B Gel [NCIt concept]
- ADA Transduced T Cell [NCIt concept]
- AFP Gene Hepatocellular Carcinoma Vaccine [NCIt concept]
- AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine [NCIt concept]
- AMP KRAS Vaccine ELI-002 [NCIt concept]
- Abipapogene Suvaplasmid [NCIt concept]
- Acmucabtagene Autoleucel [NCIt concept]
- Activated Marrow Infiltrating Lymphocytes [NCIt concept]
- Ad5-survivin-transduced Autologous Dendritic Cell Vaccine [NCIt concept]
- Ad5F35-LMP1/LMP2-Transduced Autologous Dendritic Cells [NCIt concept]
- AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine [NCIt concept]
- Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901 [NCIt concept]
- Afamitresgene Autoleucel [NCIt concept]
- Akt-1/2 Inhibitor-treated Tumor Infiltrating Lymphocytes [NCIt concept]
- Allogeneic Anti-HA-1 TCR-engineered T-cells TSC-100 [NCIt concept]
- Allogeneic Anti-HA-2 TCR-engineered T-cells TSC-101 [NCIt concept]
- Allogeneic CD19CAR-transfected Cytokine-induced Killer Cells [NCIt concept]
- Allogeneic NK-like Cells GAIA-102 [NCIt concept]
- Alpha-lactalbumin Breast Cancer Vaccine [NCIt concept]
- Alpha-type-1 Polarized Dendritic Cells [NCIt concept]
- Alrefimotide [NCIt concept]
- Aluminum Hydroxide Adjuvanted Multi-epitope SARS-CoV-2 Vaccine [NCIt concept]
- Amilomotide [NCIt concept]
- Anbalcabtagene Autoleucel [NCIt concept]
- Anitocabtagene Autoleucel [NCIt concept]
- Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087 [NCIt concept]
- Anti-CD19 CAR-IL-18-expressing Autologous T-lymphocytes [NCIt concept]
- Anti-CD19-CAR Retroviral Vector-Transduced Autologous T Cells [NCIt concept]
- Anti-CD19-CAR-CD28/CD20-CAR-4-1BB-expressing Autologous T-lymphocytes Hu1928-Hu20BB [NCIt concept]
- Anti-CD19-CD20-CAR-CD3zeta-4-1BB-expressing Autologous T-lymphocytes [NCIt concept]
- Anti-CD20-CAR-CD3zeta-4-1BB-expressing Autologous T-lymphocyte Cells [NCIt concept]
- Anti-CD22 scFv TCRz:41BB-CAR Lentiviral Vector-transduced Autologous T-lymphocytes [NCIt concept]
- Anti-CD22-CAR m971-BBz Lentiviral Vector-transduced Autologous T Lymphocytes [NCIt concept]
- Anti-CD3 OKT3/Anti-EGFR Bispecific Antibody Armed Activated T Lymphocytes [NCIt concept]
- Anti-CD3 OKT3/Humanized Anti-GD2 3F8 Bispecific Antibody-activated T Lymphocytes [NCIt concept]
- Anti-CD3/Anti-EGFR-bispecific Monoclonal Antibody-armed Activated Autologous T-lymphocytes [NCIt concept]
- Anti-CEA IgCD28TCR-Transduced Autologous T Cells [NCIt concept]
- Anti-CEA-CAR Autologous T Lymphocytes [NCIt concept]
- Anti-EGFRvIII-CAR-CD3/EGFR BiTE-transduced Autologous T-lymphocytes CARv3-TEAM-E [NCIt concept]
- Anti-FL(FITC-E2) CAR T Cells [NCIt concept]
- Anti-FOLR1 CoStAR-expressing Autologous Tumor-infiltrating Lymphocytes ITIL-306 [NCIt concept]
- Anti-GD2/Anti-CD56 4SCAR-expressing Bispecific T-cells [NCIt concept]
- Anti-GD2/Anti-CD70 4SCAR-expressing Bispecific T-cells [NCIt concept]
- Anti-GD2/PSMA/CD276 4SCAR-expressing T-cells [NCIt concept]
- Anti-GPC3-CAR Autologous T Lymphocytes [NCIt concept]
- Anti-Glypican 3-scFvGC33-CAR-expressing T Lymphocytes [NCIt concept]
- Anti-GnRH Vaccine PEP223 [NCIt concept]
- Anti-HER2-CAR Autologous CMV-Specific Cytotoxic T-Lymphocytes [NCIt concept]
- Anti-HLA-A2/NY-ESO-1 TCR-transduced Autologous T Lymphocytes [NCIt concept]
- Anti-Her-2-CAR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes [NCIt concept]
- Anti-K-RAS G12D mTCR-transduced Autologous Peripheral Blood Lymphocytes [NCIt concept]
- Anti-K-RAS G12V mTCR-transduced Autologous Peripheral Blood Lymphocytes [NCIt concept]
- Anti-LeY-CAR-transduced Autologous T-Lymphocytes [NCIt concept]
- Anti-MART-1 TCR Retroviral Vector-Transduced Autologous TIL [NCIt concept]
- Anti-MUC1 CAR-transduced Autologous T-lymphocytes [NCIt concept]
- Anti-NY-ESO-1 TCR LV-transduced Autologous T-Cells TAEST16001 [NCIt concept]
- Anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes [NCIt concept]
- Anti-PSMA/Anti-CD70 4SCAR-expressing Bispecific T-cells [NCIt concept]
- Anti-TRBC1-CAR-CD3zeta-4-1BB-RQR8-expressing Autologous T-lymphocyte Cells AUTO4 [NCIt concept]
- Anti-VEGFR2-CAR Retroviral Vector-transduced Autologous T-lymphocytes [NCIt concept]
- Anti-gp100 TCR Retroviral Vector-Transduced Autologous PBL [NCIt concept]
- Anti-gp100 TCR Retroviral Vector-Transduced Autologous TIL [NCIt concept]
- Anti-hCD70-CAR Retroviral Vector-transduced Autologous PBLs [NCIt concept]
- Anti-human Chorionic Gonadotropin Vaccine [NCIt concept]
- Anti-mesothelin CAR Vector-transduced Autologous T-lymphocytes [NCIt concept]
- Anti-mesothelin CIR mRNA-electroporated Autologous T Cells [NCIt concept]
- Anti-mesothelin iCasp9M28z CAR-transduced Autologous T Lymphocytes [NCIt concept]
- Anti-p53 T-Cell Receptor-Transduced Peripheral Blood Lymphocytes [NCIt concept]
- Anti-thyroglobulin mTCR-transduced Autologous Peripheral Blood Lymphocytes [NCIt concept]
- Arginase-1 Long Peptide Vaccine [NCIt concept]
- Arginase-1 Peptide Vaccine [NCIt concept]
- Astuprotimut-R [NCIt concept]
- Attenuated Live Listeria monocytogenes Encoding KRAS G12D [NCIt concept]
- Autologous 19-28z/IL-18 CAR T-lymphocytes [NCIt concept]
- Autologous 1928T2z CAR T-cells WZTL-002 [NCIt concept]
- Autologous 4-1BB Selected Tumor Infiltrating Lymphocytes [NCIt concept]
- Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707 [NCIt concept]
- Autologous AFP Specific T Cell Receptor Transduced T Cells C-TCR055 [NCIt concept]
- Autologous ALPG/ALPP-targeted Anti-MSLN CAR-Fas/PTPN2 shRNA-miR-expressing T-lymphocytes AB-1015 [NCIt concept]
- Autologous AXL-targeted CAR T-cells CCT301-38 [NCIt concept]
- Autologous Active IL-7 Receptor Co-expressing GD2-specific CAR T-cells [NCIt concept]
- Autologous Alpha-PNE Switchable CAR-T Cells CLBR001 [NCIt concept]
- Autologous Alpha-PNE Switchable CAR-T Cells CLBR001 and CD19-specific Adapter Molecule SWI019 [NCIt concept]
- Autologous Anti-ALPP CAR Retroviral Vector-transduced T Cells [NCIt concept]
- Autologous Anti-B7-H3 CAR Retroviral Vector-transduced T Cells [NCIt concept]
- Autologous Anti-B7-H3 CAR T Cells [NCIt concept]
- Autologous Anti-B7-H3 CAR T Cells CAR.B7-H3T [NCIt concept]
- Autologous Anti-B7-H3 CAR-iC9-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-B7-H3/CD19 CAR T-cells SCRI-CARB7H3(s)x19 [NCIt concept]
- Autologous Anti-BCMA CAR T-cells IM21 [NCIt concept]
- Autologous Anti-BCMA CAR T-cells MCARH125 [NCIt concept]
- Autologous Anti-BCMA CAR T-cells PHE885 [NCIt concept]
- Autologous Anti-BCMA CAR T-cells spCART-269 [NCIt concept]
- Autologous Anti-BCMA CAR-transduced T-cells KITE-585 [NCIt concept]
- Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11 [NCIt concept]
- Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101 [NCIt concept]
- Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes [NCIt concept]
- Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217 [NCIt concept]
- Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells C-CAR088 [NCIt concept]
- Autologous Anti-BCMA-CAR-4-1BB-expressing T-cells NXC-201 [NCIt concept]
- Autologous Anti-BCMA-CAR-TCRz/4-1BB-expressing T-lymphocytes CART-BCMA [NCIt concept]
- Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143 [NCIt concept]
- Autologous Anti-BCMA-CAR-mRNA-transfected CD8+ T-lymphocytes [NCIt concept]
- Autologous Anti-BCMA/CS1 Bispecific CAR-T Cells [NCIt concept]
- Autologous Anti-CD123 CAR TCR/4-1BB-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-CD123 CAR-T Cells [NCIt concept]
- Autologous Anti-CD147 CAR T-cells [NCIt concept]
- Autologous Anti-CD19 AbTCR-expressing T-lymphocytes EB103 [NCIt concept]
- Autologous Anti-CD19 CAR T Cells KITE-197 [NCIt concept]
- Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx [NCIt concept]
- Autologous Anti-CD19 CAR T-cells IM19 [NCIt concept]
- Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T Lymphocytes BinD19 [NCIt concept]
- Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19 [NCIt concept]
- Autologous Anti-CD19 CAR Vector-transduced T Cells pCAR-19B [NCIt concept]
- Autologous Anti-CD19 CAR-4-1BB-CD3zeta-expressing T-cells CNCT19 [NCIt concept]
- Autologous Anti-CD19 CAR-CD28 T-cells ET019002 [NCIt concept]
- Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells [NCIt concept]
- Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells PZ01 [NCIt concept]
- Autologous Anti-CD19 CAR-CD8alpha-CD28-CD3zeta T Cells KYV 101 [NCIt concept]
- Autologous Anti-CD19 CAR-IL-18-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-CD19 CAR-T Cells CABA-201 [NCIt concept]
- Autologous Anti-CD19 CAR-T Cells GC019F [NCIt concept]
- Autologous Anti-CD19 CAR-T Cells TBI-1501 [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T Lymphocytes [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T-lymphocytes CLIC-1901 [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563 [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T-lymphocytes UF-KURE19 [NCIt concept]
- Autologous Anti-CD19 Chimeric Antigen Receptor T-cells C-CAR011 [NCIt concept]
- Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19 [NCIt concept]
- Autologous Anti-CD19 DASH CAR-T Cells [NCIt concept]
- Autologous Anti-CD19 T-cell Receptor Fusion Construct T-cells TC-110 [NCIt concept]
- Autologous Anti-CD19 T-cell Receptor T cells ET190L1 [NCIt concept]
- Autologous Anti-CD19 TAC-T cells TAC01-CD19 [NCIt concept]
- Autologous Anti-CD19/Anti-CD20-CAR-CD28-4-1BB-CD3zeta-EGFRt+-expressing Tn/mem Cells [NCIt concept]
- Autologous Anti-CD19/Anti-CD79b CAR-expressing Bispecific T-cells [NCIt concept]
- Autologous Anti-CD19/CD20 Bispecific CAR-T Cells IMPT-314 [NCIt concept]
- Autologous Anti-CD19/CD20 Bispecific Nanobody-based CAR-T cells [NCIt concept]
- Autologous Anti-CD19/CD20 CAR-T Cells KITE-363 [NCIt concept]
- Autologous Anti-CD19/CD22 CAR T-cells AUTO3 [NCIt concept]
- Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014 [NCIt concept]
- Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing T Lymphocytes [NCIt concept]
- Autologous Anti-CD19CAR-4-1BB/CD3zeta-HER2tG-expressing CD4+/CD8+ T-lymphocytes SCRI-huCAR19v2 [NCIt concept]
- Autologous Anti-CD19CAR-CD28tm/4-1BB/CD3zeta-HER2tG-expressing CD4+/CD8+ T-lymphocytes SCRI-huCAR19v1 [NCIt concept]
- Autologous Anti-CD19CAR-CD3zeta-4-1BB-IL-15-PD1-expressing Tri-functional T-lymphocytes [NCIt concept]
- Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells [NCIt concept]
- Autologous Anti-CD1a CAR T Cells [NCIt concept]
- Autologous Anti-CD1a CAR T Cells OC-1 [NCIt concept]
- Autologous Anti-CD20 CAR T-cells C-CAR066 [NCIt concept]
- Autologous Anti-CD20 CAR Transduced CD4/CD8 Enriched T-cells MB-CART20.1 [NCIt concept]
- Autologous Anti-CD20CAR-CD28-4-1BB-CD3zeta T-lymphocytes MB-106 [NCIt concept]
- Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s [NCIt concept]
- Autologous Anti-CD22 CAR-T Cells CLIC-2201 [NCIt concept]
- Autologous Anti-CD22 CAR-expressing T-cells SCRI-CAR22v2 [NCIt concept]
- Autologous Anti-CD3/Anti-SLAMF7 Bispecific Antibody-armed Activated T-lymphocytes [NCIt concept]
- Autologous Anti-CD30 CAR T Cells HSP-CAR30 [NCIt concept]
- Autologous Anti-CD33 CAR-mbIL15-Safety Switch T-cells PRGN-3006 [NCIt concept]
- Autologous Anti-CD38 A2 CAR2-expressing T-cells [NCIt concept]
- Autologous Anti-CD4 CAR T-cells LB1901 [NCIt concept]
- Autologous Anti-CD7 CAR T Cells PA3-17 [NCIt concept]
- Autologous Anti-CD7 CAR T-cells SENL101 [NCIt concept]
- Autologous Anti-CD7 CAR/28zeta CRISPR-edited T-lymphocytes [NCIt concept]
- Autologous Anti-CD7-CAR-CD28zeta T-cells [NCIt concept]
- Autologous Anti-CD79a/anti-CD20 CAR T-cells bbT369 [NCIt concept]
- Autologous Anti-CD79b CAR-T Cells JV-213 [NCIt concept]
- Autologous Anti-CDH17 CAR-T Cells CHM-2101 [NCIt concept]
- Autologous Anti-CEA CAR/HLA-A*02-gated Inhibitory Receptor/B2M shRNA-expressing T-lymphocytes A2B530 [NCIt concept]
- Autologous Anti-CLDN18.2 TAC T-cells TAC01-CLDN18.2 [NCIt concept]
- Autologous Anti-CLDN6 CAR-NK Cells [NCIt concept]
- Autologous Anti-CLL-1-CAR T-lymphocytes BG1805 [NCIt concept]
- Autologous Anti-CLL-1-CAR T-lymphocytes KITE-222 [NCIt concept]
- Autologous Anti-CS1 Hinge-optimized CAR-4-1BB-EGFRt-expressing Memory-enriched T-cells [NCIt concept]
- Autologous Anti-CSPG4 CAR-iC9-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-Claudin18.2 CAR T-cells LB1908 [NCIt concept]
- Autologous Anti-DLL3 CAR-T Cells LB2102 [NCIt concept]
- Autologous Anti-EBV CAR T Cells BRG01 [NCIt concept]
- Autologous Anti-EGFR CAR-transduced CXCR 5-modified T-lymphocytes [NCIt concept]
- Autologous Anti-EGFR/Anti-IL13Ralpha2 CAR T-cells [NCIt concept]
- Autologous Anti-EGFRvIII 4SCAR-IgT Cells [NCIt concept]
- Autologous Anti-EGFRvIII synNotch Receptor-induced Anti-EphA2/IL-13Ralpha2 CAR-T Cells [NCIt concept]
- Autologous Anti-FLT3 CAR T Cells AMG 553 [NCIt concept]
- Autologous Anti-FLT3 CAR T Cells TAA05 [NCIt concept]
- Autologous Anti-FSHR CER-4-1BB/CD3zeta-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-FcRL5 CAR-T Cells [NCIt concept]
- Autologous Anti-GD2-CAR-BBz-iCasp9 Retroviral Vector-transduced T Lymphocytes [NCIt concept]
- Autologous Anti-GD2/Anti-PSMA 4SCAR-expressing Bispecific T-cells [NCIt concept]
- Autologous Anti-GD2CAR-CD28-CD3zeta-IL-15-expressing Natural Killer T-cells [NCIt concept]
- Autologous Anti-GFRa4 CAR-TCR-zeta-4-1BB-expressing T-cells [NCIt concept]
- Autologous Anti-GPC2-CAR T-cells [NCIt concept]
- Autologous Anti-GPC3 CAR T Cells BOXR1030 [NCIt concept]
- Autologous Anti-GPC3 CAR T-lymphocytes JWAT204 [NCIt concept]
- Autologous Anti-GPC3-CAR T-lymphocytes Ori-C101 [NCIt concept]
- Autologous Anti-GPRC5D CAR-T Cells BMS-986393 [NCIt concept]
- Autologous Anti-GPRC5D CAR-T Cells OriCAR-017 [NCIt concept]
- Autologous Anti-GPRC5D-CAR-4-1BB-expressing T-cells MCARH109 [NCIt concept]
- Autologous Anti-H3.3K27M TCR-expressing T-cells [NCIt concept]
- Autologous Anti-HER2 CAR T-cells CCT303-406 [NCIt concept]
- Autologous Anti-HER2 CAR-CD28 T Cells [NCIt concept]
- Autologous Anti-HER2 CAR-T Cells [NCIt concept]
- Autologous Anti-HER2-CAR-4-1BB-CD3zeta-CD19t+-expressing Tcm-enriched T-lymphocytes [NCIt concept]
- Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202 [NCIt concept]
- Autologous Anti-HLA-A*0201/AFP CAR T-cells ET1402L1 [NCIt concept]
- Autologous Anti-HLA-G CAR-T Cells IVS-3001 [NCIt concept]
- Autologous Anti-HPV-16 E6 T-cell Receptor Gene-engineered Peripheral Blood Lymphocytes [NCIt concept]
- Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100 [NCIt concept]
- Autologous Anti-IL-1RAP CAR T-cells CCTx-001 [NCIt concept]
- Autologous Anti-ILT3 CAR-T Cells [NCIt concept]
- Autologous Anti-KK-LC-1 TCR-expressing T-cells [NCIt concept]
- Autologous Anti-L1CAM-CAR-EGFRt-expressing T-cells [NCIt concept]
- Autologous Anti-LGR5 CAR-T Cells CNA3103 [NCIt concept]
- Autologous Anti-LILRB4 CAR-T Cells [NCIt concept]
- Autologous Anti-MAGE-A1 TCR-engineered T-cells TSC-204-A0201 [NCIt concept]
- Autologous Anti-MAGE-A1 TCR-engineered T-cells TSC-204-C0702 [NCIt concept]
- Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes [NCIt concept]
- Autologous Anti-MART-1 F5 TCR Tumor Infiltrating Lymphocytes [NCIt concept]
- Autologous Anti-MG7-CAR T-Lymphocytes [NCIt concept]
- Autologous Anti-MSLN CAR/HLA-A*02-gated Inhibitory Receptor/B2M shRNA-expressing T-lymphocytes A2B694 [NCIt concept]
- Autologous Anti-MUC1*-CAR-4-1BB-CD3zeta-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-MUC16 CAR-mbIL15-Safety Switch T-cells PRGN-3005 [NCIt concept]
- Autologous Anti-Muc1/CD33/CD38/CD56/CD123 Gene-engineered CAR-T Cells [NCIt concept]
- Autologous Anti-NKG2DL/Anti-CLDN18.2 Bispecific CAR-T Cells KD-496 [NCIt concept]
- Autologous Anti-NKG2DLs CAR-T Cells LEU011 [NCIt concept]
- Autologous Anti-NY-ESO-1 TCR/CD8alpha-expressing T-cells GSK3901961 [NCIt concept]
- Autologous Anti-NY-ESO-1 TCR/dnTGF-BRII-expressing T-cells GSK3845097 [NCIt concept]
- Autologous Anti-NY-ESO-1 mTCR Retroviral Vector Transduced PBLs [NCIt concept]
- Autologous Anti-PD-1 Antibody-activated Tumor-infiltrating Lymphocytes [NCIt concept]
- Autologous Anti-PD-L1-armored Anti-CD22 CAR T Cells [NCIt concept]
- Autologous Anti-PRAME TCR/CD8alphabeta-expressing T-cells IMA203CD8 [NCIt concept]
- Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-PSMA CAR-T Cells P-PSMA-101 [NCIt concept]
- Autologous Anti-PSMA CAR/CD2/dnTGF-BRII/PD-1:CD28 Switch Receptor-expressing T-cells TmPSMA-02 [NCIt concept]
- Autologous Anti-PSMA Gene-Modified T-Lymphocytes [NCIt concept]
- Autologous Anti-ROR1 CAR T-cells LYL797 [NCIt concept]
- Autologous Anti-ROR1 CAR-T Cells BMS-986403 [NCIt concept]
- Autologous Anti-ROR1 CAR-T Cells ONCT-808 [NCIt concept]
- Autologous Anti-ROR1 CAR-mbIL15-Safety Switch/Intrinsic PD-1 Blockade T-cells PRGN-3007 [NCIt concept]
- Autologous Anti-SLAMF7 CAR-expressing T-cells [NCIt concept]
- Autologous Anti-Siglec-6 CAR-T Cells [NCIt concept]
- Autologous Anti-TIM-3/Anti-CD123 CAR T-cells [NCIt concept]
- Autologous Anti-TM4SF1 CAR-T Cells [NCIt concept]
- Autologous Anti-glypican-3 CAR-IL-15-iC9-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes [NCIt concept]
- Autologous Anti-gp100:154-162 TCR Tumor Infiltrating Lymphocytes [NCIt concept]
- Autologous Anti-gp100CAR-CD3zeta-4-1BB-IL-15-PD1-expressing Tri-functional T-lymphocytes [NCIt concept]
- Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-mesothelin CAR-CD3zeta-4-1-BB-expressing T-cells [NCIt concept]
- Autologous Anti-mesothelin CAR-IL-7-CCL19-expressing T-lymphocytes TAK-103 [NCIt concept]
- Autologous Anti-mesothelin CAR-T Cells UCLM802 [NCIt concept]
- Autologous Anti-mesothelin KIR-CAR-transduced T-cells SynKIR-110 [NCIt concept]
- Autologous Anti-mesothelin M28z1XXPD1DNR CAR-expressing T-cells [NCIt concept]
- Autologous Anti-mesothelin T-cell Receptor Fusion Construct/PD-1:CD28 Switch Receptor-expressing T-cells TC-510 [NCIt concept]
- Autologous Anti-mesothelin TCR-expressing T-cells FH-TCR TMSLN [NCIt concept]
- Autologous B7-H3/EGFR806/HER2/IL13-zetakine CAR-expressing CD4+/CD8+ T-cells SC-CAR4BRAIN [NCIt concept]
- Autologous BAFF-expressing CAR T Cells LMY-920 [NCIt concept]
- Autologous BAFFR-targeting CAR T Cells [NCIt concept]
- Autologous BCMA-4-1BBz-targeted CAR T-cells [NCIt concept]
- Autologous BCMA-targeted CAR T Cells CC-98633 [NCIt concept]
- Autologous BCMA-targeted CAR T Cells LCAR-B4822M [NCIt concept]
- Autologous BCMA/TACI-targeted CAR T Cells AUTO2 [NCIt concept]
- Autologous BCMA/TACI-targeted Trimeric APRIL-based CAR T Cells [NCIt concept]
- Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F [NCIt concept]
- Autologous Bispecific CD19/CD22-targeted CAR-T Cells GC022 [NCIt concept]
- Autologous Blinatumomab-expanded T-Cells [NCIt concept]
- Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001 [NCIt concept]
- Autologous CAR T Cells U87 [NCIt concept]
- Autologous CAR T-Cells RD14-01 [NCIt concept]
- Autologous CAR-T Cells [NCIt concept]
- Autologous CAR-T Cells B4T2-001 [NCIt concept]
- Autologous CAR-engineered Regulatory T-cells SBT777101 [NCIt concept]
- Autologous CCR4-CD30CAR-CD28-CD3zeta-expressing T-Lymphocytes [NCIt concept]
- Autologous CD123-4SCAR-expressing T-cells 4SCAR123 [NCIt concept]
- Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes [NCIt concept]
- Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes MB-102 [NCIt concept]
- Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- Autologous CD138-specific CAR T-cells [NCIt concept]
- Autologous CD171-specific CAR-CD28 zeta-4-1-BB-EGFRt-expressing T Lymphocytes [NCIt concept]
- Autologous CD19 CAR+ EGFRt + CD4+ and CD8+ T Cells [NCIt concept]
- Autologous CD19 CAR-expressing CD4+/CD8+ T-cells MB-CART19.1 [NCIt concept]
- Autologous CD19-28z Chimeric Antigen Receptor-expressing T-lymphocytes [NCIt concept]
- Autologous CD19-CD8-CD28-CAR-mbIL15-HER1t T Cells [NCIt concept]
- Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells [NCIt concept]
- Autologous CD19-targeted CAR T Cells CC-97540 [NCIt concept]
- Autologous CD19-targeted CAR-T Cells GC007F [NCIt concept]
- Autologous CD19/CD22 Chimeric Antigen Receptor T-cells CT120 [NCIt concept]
- Autologous CD19/PD-1 Bispecific CAR-T Cells [NCIt concept]
- Autologous CD19CAR-CD28-CD137/CD27/CD3zeta-iCasp9-expressing T-lymphocytes [NCIt concept]
- Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T Cells [NCIt concept]
- Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes [NCIt concept]
- Autologous CD20-4SCAR-expressing T-cells 4SCAR20 [NCIt concept]
- Autologous CD22-4SCAR-expressing T-cells 4SCAR22 [NCIt concept]
- Autologous CD30CAR-CD28-CD3zeta-expressing T-Lymphocytes [NCIt concept]
- Autologous CD38-4SCAR-expressing T-cells 4SCAR38 [NCIt concept]
- Autologous CD4 and CD8 Positive Truncated CD19-expressing Antigen Presenting T-cells [NCIt concept]
- Autologous CD4+/CD8+ 4-1BB-CD3zeta-EGFR806-CAR-EGFRt/4-1BB-CD3zeta-CD19-CAR-HER2tG-expressing CARs T Cells [NCIt concept]
- Autologous CD4+/CD8+ EGFR806 Specific 4-1BB-CD3zeta-EGFRt-expressing CAR T Cells [NCIt concept]
- Autologous CD40L-expressing B-CLL Vaccine [NCIt concept]
- Autologous CD5-specific CAR-28 zeta CAR T-cells [NCIt concept]
- Autologous CD5KO Anti-CD5 CAR 4-1BB-expressing T-lymphocytes and Autologous CD5KO T-lymphocytes [NCIt concept]
- Autologous CD8 Positive PBL Sensitized to Drosophila Cell-Presented Melanoma Peptides [NCIt concept]
- Autologous CD8+ Melanoma Specific T Cells [NCIt concept]
- Autologous CD8+ SLC45A2-specific T Lymphocytes [NCIt concept]
- Autologous CEA-specific Cytotoxic T-lymphocytes [NCIt concept]
- Autologous CISH-inactivated TILs [NCIt concept]
- Autologous CLL1-CAR-CD28-expressing T-lymphocytes [NCIt concept]
- Autologous CLL1-CD33 Compound CAR T Cells [NCIt concept]
- Autologous CLTX-targeted CAR T-lymphocytes CHM 1101 [NCIt concept]
- Autologous CRISPR-Cas9 Engineered Regnase-1/SOCS1 Dual-edited Tumor Infiltrating Lymphocytes KSQ-004EX [NCIt concept]
- Autologous CRISPR-Cas9 Engineered Tumor Infiltrating Lymphocytes KSQ-001EX [NCIt concept]
- Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19 [NCIt concept]
- Autologous CRISPR-edited Tumor Infiltrating Lymphocytes GT316 [NCIt concept]
- Autologous CT-RCC-1 HERV-E-TCR-transduced-HLA-A11-restricted CD8+/CD34t+ T-cells [NCIt concept]
- Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells [NCIt concept]
- Autologous CXCR2-modified CD70 CAR T-cells [NCIt concept]
- Autologous Cervical Cancer-specific Engineered Immune Effector Cells [NCIt concept]
- Autologous Clonal Neoantigen T Cells ATL001 [NCIt concept]
- Autologous Colorectal Tumor Antigen-pulsed Dendritic Cell Vaccine [NCIt concept]
- Autologous Cultured Acute Myeloid Leukemia-specific Cytotoxic T Lymphocytes [NCIt concept]
- Autologous Cytokine-induced Killer Cells [NCIt concept]
- Autologous Cytomegalovirus-specific Cytotoxic T-lymphocytes [NCIt concept]
- Autologous Cytoplasmic Activated PD-1 CAR T-cells [NCIt concept]
- Autologous Cytotoxic T-lymphocytes Exposed to Dendritic Cells loaded with 6B11 Anti-idiotype Minibody [NCIt concept]
- Autologous Cytotoxic T-lymphocytes Induced with MUC1 Gene-transfected Dendritic Cells [NCIt concept]
- Autologous Cytotoxic T-lymphocytes Induced with MUC1 Peptide-pulsed Dendritic Cells [NCIt concept]
- Autologous Deep IL-15 Primed T-cells TRQ15-01 [NCIt concept]
- Autologous Dendritic Cells Pulsed with MART-1 (26-35) Peptide [NCIt concept]
- Autologous Desmoglein-3 Chimeric Autoantibody Receptor T-cells DSG3-CAART [NCIt concept]
- Autologous E6 T Cell Receptor Genetically-modified T Cells [NCIt concept]
- Autologous EBV-CTL CD19CAR zeta [NCIt concept]
- Autologous EGFR-specific CAR-T-Cells Expressing Anti-PD-1/CTLA-4 Antibodies [NCIt concept]
- Autologous EGFRt/19-28z/4-1BBL CAR T-Lymphocytes [NCIt concept]
- Autologous EGFRt/BCMA-41BBz-targeted CAR T Cells [NCIt concept]
- Autologous Engineered TCR-T Cells KSH01 [NCIt concept]
- Autologous Engineered TCR-T Cells KSX01 [NCIt concept]
- Autologous Enhanced NY-ESO-1 TCR Engineered T-cells GSK4427296 [NCIt concept]
- Autologous Epstein-Barr Virus-Specific Cytotoxic T Lymphocytes [NCIt concept]
- Autologous FRa-4SCAR-expressing T-cells 4SCAR-FRa [NCIt concept]
- Autologous GCC-targeting CAR T Cells GCC19CART [NCIt concept]
- Autologous GCC-targeting CAR T-cells LCAR-G08 [NCIt concept]
- Autologous GPC3/NY-ESO-1/AFP specific CD8-positive T-lymphocytes [NCIt concept]
- Autologous Gamma Delta T-cell Receptor-expressing T-cells TEG002 [NCIt concept]
- Autologous Gamma-retroviral MSGV1 139 scFv EGFRvIII CAR Gene-modified T Cells [NCIt concept]
- Autologous Gene-modified Gamma Delta T-cells [NCIt concept]
- Autologous Gene-modified PD-1-positive T-lymphocytes Sc610 [NCIt concept]
- Autologous Gene-modified PD-1-positive T-lymphocytes ScTIL210 [NCIt concept]
- Autologous HBV-specific TCR-expressing T-lymphocytes SCG101 [NCIt concept]
- Autologous HBV-specific TCR-redirected T-Lymphocytes [NCIt concept]
- Autologous HER2-CAR-modified Adenovirus-specific Cytotoxic T-lymphocytes [NCIt concept]
- Autologous HER2-specific/EGFRt-expressing CD4/CD8-positive CAR T-cells [NCIt concept]
- Autologous HER2-targeted Dual-switch CAR-T Cells BPX-603 [NCIt concept]
- Autologous HIV Gag-specific CD4+ T-cells AGT103-T [NCIt concept]
- Autologous HLA-A*11:01 KRASG12V-specific TCR-expressing CD8- and CD4-positive T-lymphocytes AFNT-211 [NCIt concept]
- Autologous HPV E6/E7-targeting T-cells [NCIt concept]
- Autologous HPV-16/18 E6/E7-specific TGF-beta-resistant T Lymphocytes [NCIt concept]
- Autologous HPV-specific Cytotoxic T Lymphocytes [NCIt concept]
- Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439 [NCIt concept]
- Autologous HPV16/HPV18/Survivin-specific CD8+ T-cells NEXI-003 [NCIt concept]
- Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858 [NCIt concept]
- Autologous Human Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes [NCIt concept]
- Autologous IL-12/Multi-targeted Primed T-cells RPTR 168 [NCIt concept]
- Autologous IL-15-expanded HER2-specific CD4+ T-cells [NCIt concept]
- Autologous IL-15/IL-21-armored Anti-glypican-3 CAR T-cells [NCIt concept]
- Autologous IL-2-expressing B-CLL Vaccine [NCIt concept]
- Autologous IL-21-Modulated CD8+ MART1-Specific T Cells [NCIt concept]
- Autologous IL-7-expanded HER2-specific CD4+ T-cells [NCIt concept]
- Autologous IL-7-expressing TILs ADP-TILIL7 [NCIt concept]
- Autologous IL-7/CCL19-expressing Anti-GM2 CAR T Cells NIB-101 [NCIt concept]
- Autologous IL-7Ra-expressing Tris-CAR T-cells [NCIt concept]
- Autologous Interleukin-15-armored Anti-glypican-3 CAR-iC9-expressing T-lymphocytes [NCIt concept]
- Autologous KRAS G12D-specific HLA-C*08:02-restricted TCR Gene Engineered T-lymphocytes NT-112 [NCIt concept]
- Autologous KRAS Mutant-specific TCRs Gene Engineered PBLs [NCIt concept]
- Autologous LMP1-/LMP2- Specific Cytotoxic T-Lymphocytes [NCIt concept]
- Autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T-lymphocytes YT-E001 [NCIt concept]
- Autologous Lymphoid Effector Cells Specific Against Tumor Cells [NCIt concept]
- Autologous MAGE-A10-specific HLA-A2-restricted TCR c796 Gene-engineered Lymphocytes [NCIt concept]
- Autologous MAGE-A3-specific HLA-A*01-Restricted T Cell Receptor Gene Engineered Lymphocytes [NCIt concept]
- Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718 [NCIt concept]
- Autologous MAGE-C2-specific HLA-A2-restricted TCR T-lymphocytes [NCIt concept]
- Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR [NCIt concept]
- Autologous MG7-pulsed Dendritic Cell Vaccine [NCIt concept]
- Autologous MUC1-activated T-cells [NCIt concept]
- Autologous Memory Cytokine-enriched Natural Killer Cells [NCIt concept]
- Autologous Mesothelin-specific CAR-T Cells [NCIt concept]
- Autologous Mesothelin-specific CAR-T-Cells Expressing Anti-PD-1/CTLA-4 Antibodies [NCIt concept]
- Autologous MuSK-CD3z/4-1BB-expressing Chimeric Autoantibody Receptor T-cells MuSK-CAART [NCIt concept]
- Autologous Multiple Antigen-specific T-cells MASE-T [NCIt concept]
- Autologous NKG2D CAR T Cells KD-025 [NCIt concept]
- Autologous NKG2D CAR T-cells CYAD-02 [NCIt concept]
- Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01 [NCIt concept]
- Autologous NKG2D CAR-expressing T-lymphocytes ASP2802 [NCIt concept]
- Autologous NY-ESO-1 TCR-targeted T Lymphocytes [NCIt concept]
- Autologous NY-ESO-1-Melanoma-Specific CD8+ T-lymphocytes [NCIt concept]
- Autologous NY-ESO-1-redirected CRISPR-edited T Cells [NCIt concept]
- Autologous NY-ESO-1-specific CD8-positive T Lymphocytes [NCIt concept]
- Autologous Natural Killer Cell-like CTLs [NCIt concept]
- Autologous Natural Killer Cells SNK01 [NCIt concept]
- Autologous Nectin-4/FAP-targeted CAR-T Cells [NCIt concept]
- Autologous Neoantigen-specific T-lymphocytes GEN-011 [NCIt concept]
- Autologous Orthogonal IL-2Rbeta-expressing Anti-CD19 CAR T-cells SYNCAR-001 [NCIt concept]
- Autologous Ovarian Cancer Immunogene-modified T Lymphocytes [NCIt concept]
- Autologous Ovarian Cancer-specific Antigens-pulsed Dendritic Cells Cellgram-DC [NCIt concept]
- Autologous Ovarian Cancer-specific Cytotoxic T-Lymphocytes [NCIt concept]
- Autologous PBLs Retrovirally-transduced with TCRs Targeting Neoantigens [NCIt concept]
- Autologous PBTL CD19CAR-28 zeta [NCIt concept]
- Autologous PD-1 Antibody-expressing Mesothelin-specific CAR-T Cells [NCIt concept]
- Autologous PD-1 Nanobody-expressing Anti-MSLN CAR T-cells [NCIt concept]
- Autologous PD-1-knockout Tumor-infiltrating Lymphocytes IOV-4001 [NCIt concept]
- Autologous PD-1-targeted Chimeric Switch Receptor-modified T Lymphocytes [NCIt concept]
- Autologous PD-L1/CD80/CD86-targeted CAR-T Cells [NCIt concept]
- Autologous PD1-inhibiting Anti-CD19 4-1BB CAR T Cells [NCIt concept]
- Autologous PD1-knockout CD19-specific CAR T Cells [NCIt concept]
- Autologous PD1-knockout CD19-specific CAR T-cells BRL-201 [NCIt concept]
- Autologous PRAME-targeting TCR-engineered T-cells IMA203 [NCIt concept]
- Autologous PRAME-targeting TCR-modified T Cells MDG1011 [NCIt concept]
- Autologous PSMA-4SCAR-expressing T-cells 4SCAR-PSMA [NCIt concept]
- Autologous PSMA-inducible Anti-CA9 CAR T-cells AB-2100 [NCIt concept]
- Autologous PSMA-specific TGFb-resistant CAR T Cells [NCIt concept]
- Autologous Peripheral Blood Lymphocytes Cotransduced with Retroviral Vectors Encoding Inducible IL-12 and Anti-NY-ESO-1 TCR [NCIt concept]
- Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001 [NCIt concept]
- Autologous Polyclonal Tumor Infiltrating Lymphocytes LYL845 [NCIt concept]
- Autologous Prostate Cancer-specific Antigens-pulsed Dendritic Cells Cellgram-DC-PC [NCIt concept]
- Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601 [NCIt concept]
- Autologous ROR2-targeted CAR T-cells CCT301-59 [NCIt concept]
- Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201 [NCIt concept]
- Autologous Retroviral Vector MSGV1-transduced Anti-PSCA-8T28Z CAR Gamma Delta T-cells [NCIt concept]
- Autologous T-lymphocytes-expressing NY-ESO-1-C259-specific Enhanced T-cell Receptors [NCIt concept]
- Autologous TAAs-loaded Autologous Dendritic Cells AV-GBM-1 [NCIt concept]
- Autologous TCR-engineered T-cells IMA201 [NCIt concept]
- Autologous TCR-engineered T-cells IMA202 [NCIt concept]
- Autologous TCRm-expressing T-cells ET140203 [NCIt concept]
- Autologous TGFbeta-Resistant HER2/EBV-Specific Cytotoxic T Lymphocytes [NCIt concept]
- Autologous TNS9.3.55-transduced CD34-positive Cells [NCIt concept]
- Autologous TP53 R175H Mutant-specific HLA-A*02:01-restricted TCR Gene Engineered T-lymphocytes NT-175 [NCIt concept]
- Autologous TROP2-CAR-transduced PD-1-positive T Cells T60c [NCIt concept]
- Autologous Tn-MUC1-specific CAR T-lymphocytes [NCIt concept]
- Autologous Tolerogenic Proinsulin Peptide-loaded Dendritic Cells PIpepTolDC [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes BST02 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes C-TIL051 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes C-TIL052A [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes GT101 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes GT201 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes HV-101 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes ITIL-168 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes LM103 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes LN-145 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes LN-145-S1 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes MDA-TIL [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes TBio-4101 [NCIt concept]
- Autologous Tumor-draining Lymph Node-derived Lymphocytes [NCIt concept]
- Autologous Tumor-infiltrating Lymphocytes GC101 [NCIt concept]
- Autologous Tumor-infiltrating Lymphocytes HS-IT101 [NCIt concept]
- Autologous Tumor-infiltrating Lymphocytes-Central Memory T-cells [NCIt concept]
- Autologous UCD19 CAR T Cells [NCIt concept]
- Autologous Universal CAR-expressing T-lymphocytes UniCAR02-T [NCIt concept]
- Autologous Vaccine-enhanced Ex Vivo Activated Cancer Neoantigens-specific T-cells TVI-Brain-1 [NCIt concept]
- Autologous WT1-TCRc4 Gene-transduced CD8-positive Tcm/Tn Lymphocytes [NCIt concept]
- Autologous WT1-directed CRISPR/Cas9-engineered TCR-T Cells NTLA-5001 [NCIt concept]
- Autologous c-Met/PD-L1-specific CAR T-cells [NCIt concept]
- Autologous dnTGF-BRII-armored Anti-GPC3 CAR T-cells AZD5851 [NCIt concept]
- Autologous dnTGF-BRII-armored Anti-STEAP2 CAR T-cells AZD0754 [NCIt concept]
- Autologous iC9-GD2-CAR-expressing VZV-specific T Lymphocytes [NCIt concept]
- Autologous iC9-GD2CAR-CD28-CD3zeta-IL-15-expressing T-lymphocytes [NCIt concept]
- Autologous iC9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing T-lymphocytes [NCIt concept]
- Autologous iCASP9-CD19-expressing T-Lymphocytes [NCIt concept]
- Autologous iCasp9-deltaNGFR-CD19CAR-expressing T Cells [NCIt concept]
- Autologous mRNA-modified Anti-cMET CAR-T Cells [NCIt concept]
- Autologous mbIL-12-expressing Tumor Infiltrating Lymphocytes GT202 [NCIt concept]
- Axalimogene Filolisbac [NCIt concept]
- Axicabtagene Ciloleucel [NCIt concept]
- Baltaleucel-T [NCIt concept]
- Berzofsky Ras/P53 Peptide Vaccine [NCIt concept]
- Besvatresgene Autoleucel [NCIt concept]
- Betibeglogene Autotemcel [NCIt concept]
- Brexucabtagene Autoleucel [NCIt concept]
- CAP-2 (CEA Peptide 9-mer) [NCIt concept]
- CAP-3 (CEA Peptide 9-mer) [NCIt concept]
- CBL-B Inhibitor-treated Autologous Tumor-infiltrating Lymphocytes DeTIL-0255 [NCIt concept]
- CD137L/Epstein-Barr Virus-Targeting Autologous Dendritic Cell Vaccine [NCIt concept]
- CD19CAR-CD3zeta-4-1BB-CD28-expressing Autologous T-Lymphocytes [NCIt concept]
- CD19CAR-CD3zeta-expressing Autologous T lymphocytes [NCIt concept]
- CD3/CD28 Costimulated Autologous T-Cells [NCIt concept]
- CD30 CAR-expressing Autologous T Lymphocytes [NCIt concept]
- CD33-specific CAR Lentiviral Vector-transduced Allogeneic T-lymphocytes [NCIt concept]
- CD33-specific CAR Lentiviral Vector-transduced Autologous T-lymphocytes [NCIt concept]
- CD33CAR-CD3zeta-4-1BB-expressing Autologous T-Lymphocytes [NCIt concept]
- CD4-specific Telomerase Peptide Vaccine UCPVax [NCIt concept]
- CD40L-augmented Autologous Tumor Infiltrating Lymphocytes [NCIt concept]
- CD8 Enriched Young Autologous Tumor-infiltrating Lymphocytes [NCIt concept]
- CEA RNA-pulsed Autologous Human Cultured Dendritic Cells [NCIt concept]
- CHP-HER-2 Peptide Vaccine [NCIt concept]
- CMVpp65-A*0201 Peptide Vaccine [NCIt concept]
- COVID-19 Vaccine MVC-COV1901 [NCIt concept]
- CTP-37-DT Vaccine [NCIt concept]
- CXCR2-transduced Autologous Tumor Infiltrating Lymphocytes [NCIt concept]
- Carcinoembryonic Antigen Peptide [NCIt concept]
- Carcinoembryonic Antigen Peptide 1 [NCIt concept]
- Carcinoembryonic Antigen Peptide 1-6D [NCIt concept]
- Carcinoembryonic Antigen Peptide-1 Vaccine [NCIt concept]
- Cenzileucel [NCIt concept]
- Cesnicabtagene Autoleucel [NCIt concept]
- Ciltacabtagene Autoleucel [NCIt concept]
- Colorectal Cancer Peptide Vaccine PolyPEPI1018 [NCIt concept]
- Colorectal Tumor-Associated Peptides Vaccine IMA910 [NCIt concept]
- DEPDC1/MPHOSH1 Peptide Vaccine [NCIt concept]
- DNAJB1-PRKACA Fusion Kinase Peptide Vaccine [NCIt concept]
- DNR-expressing Nasopharyngeal Carcinoma-specific Cytotoxic T-Lymphocytes [NCIt concept]
- DPT/BCG/Measles/Serratia/Pneumococcus Vaccine [NCIt concept]
- DPT/Typhoid/Staphylococcus aureus/Paratyphoid A/Paratyphoid B Vaccine [NCIt concept]
- Dimerizing Agent Regulated Immunoreceptor Complex-expressing CD33-specific Autologous CAR T Cells SC-DARIC33 [NCIt concept]
- Disomotide [NCIt concept]
- Durcabtagene Autoleucel [NCIt concept]
- E1M(184V) Peptide Vaccine [NCIt concept]
- EBV LMP-2A-specific Autologous CD8+ T-cells [NCIt concept]
- ECT204 Transgene-transduced Autologous T Cells ECT204 [NCIt concept]
- EF-1 Peptide [NCIt concept]
- EF-2 Peptide [NCIt concept]
- EFS-ADA Lentiviral Vector-transduced CD34-positive Autologous Lymphocytes [NCIt concept]
- EGF Vaccine EGF-PTI [NCIt concept]
- EGFR CAR-CD3zeta-4-1BB-expressing Autologous T-Lymphocytes [NCIt concept]
- EGFRBi-Armed Autologous T Cells [NCIt concept]
- EGFRvIII Peptide Vaccine [NCIt concept]
- EGFRvIII-specific CAR-transduced Autologous T Lymphocytes [NCIt concept]
- ESO-1 (161-180) Peptide Vaccine [NCIt concept]
- ESO-1 Reactive Autologous Peripheral Blood Lymphocyte [NCIt concept]
- ESO-1 Reactive Autologous Tumor Infiltrating Lymphocyte [NCIt concept]
- ESO-1:157-165(165V) Peptide [NCIt concept]
- ESR1 Peptides/GM-CSF/Montanide ISA Vaccine [NCIt concept]
- Elatipepimut-S [NCIt concept]
- Elpamotide [NCIt concept]
- Eltrapuldencel-T [NCIt concept]
- Emepepimut-S [NCIt concept]
- Enavermotide [NCIt concept]
- EpCAM-specific CAR-expressing Autologous T-lymphocytes [NCIt concept]
- Equecabtagene Autoleucel [NCIt concept]
- Ex Vivo-Expanded HER2-Specific T Cells [NCIt concept]
- Ex Vivo-activated Autologous Lymph Node Lymphocytes [NCIt concept]
- Ex Vivo-expanded Autologous T Cells IMA101 [NCIt concept]
- FGF-5:172-176 / 217-220 Peptide [NCIt concept]
- Fencabtagene Autoleucel [NCIt concept]
- Firicabtagene Autoleucel [NCIt concept]
- FrSh61 (MEA) VHL33 Peptide [NCIt concept]
- G250 Peptide Vaccine [NCIt concept]
- GD2-CAR-expressing Autologous T-lymphocytes [NCIt concept]
- Gag:267-274 Peptide Vaccine [NCIt concept]
- Galinpepimut-S [NCIt concept]
- Gavocabtagene Autoleucel [NCIt concept]
- Gene-edited Autologous Neoantigen-targeted NeoTCR-P1 T-cells [NCIt concept]
- Glioblastoma Multiforme Multipeptide Vaccine IMA950 [NCIt concept]
- H3K27M Long Peptide Vaccine [NCIt concept]
- HER-2-positive B-cell Peptide Antigen P467-DT-CRM197/Montanide Vaccine IMU-131 [NCIt concept]
- HER-2/neu Peptide Vaccine [NCIt concept]
- HER2/neu Peptide Vaccine GLSI-100 [NCIt concept]
- HIV Peptide Vaccine [NCIt concept]
- HIVgP160 Vaccine [NCIt concept]
- HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine [NCIt concept]
- HLA-A*0201-Restricted VEGFR1 Peptide Vaccine [NCIt concept]
- HLA-A*0201-Restricted VEGFR1-VEGFR2 Multipeptide Vaccine [NCIt concept]
- HLA-A*0201-restricted TRP2-gp100-EphA2-HER2 Multipeptide Vaccine [NCIt concept]
- HLA-A*2402-Restricted CDCA1-A24-56 Peptide Vaccine [NCIt concept]
- HLA-A*2402-Restricted CDCA1-KIF20A Multipeptide Vaccine [NCIt concept]
- HLA-A*2402-Restricted CDCA1-URLC10-KIF20A-DEPDC1-MPHOSPH1 Multipeptide Vaccine [NCIt concept]
- HLA-A*2402-Restricted KOC1-TTK-CO16-DEPDC1-MPHOSPH1 Multipeptide Vaccine [NCIt concept]
- HLA-A*2402-Restricted Multipeptide Vaccine S-488410 [NCIt concept]
- HLA-A*2402-Restricted URLC10 Peptides Vaccine [NCIt concept]
- HLA-A*2402-Restricted URLC10-CDCA1-KIF20A Multipeptide Vaccine [NCIt concept]
- HLA-A*2402-Restricted URLC10-CDCA1-VEGFR1-VEGFR2 Multipeptide Vaccine [NCIt concept]
- HLA-A*2402-Restricted URLC10-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine [NCIt concept]
- HLA-A*2402-Restricted URLC10-TTK-KOC1 Multipeptide Vaccine [NCIt concept]
- HLA-A*2402-Restricted URLC10-TTK-VEGFR1-VEGFR2 Multipeptide Vaccine [NCIt concept]
- HLA-A*2402-Restricted VEGFR1 Peptide Vaccine [NCIt concept]
- HLA-A*2402-Restricted VEGFR1/2 Multipeptide Vaccine [NCIt concept]
- HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine [NCIt concept]
- HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine [NCIt concept]
- HLA-A2, A3-Restricted FGF-5 Peptides/Montanide ISA-51 Vaccine [NCIt concept]
- HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine [NCIt concept]
- HLA-B44-Restricted Tyrosinase Peptide [NCIt concept]
- HLA-DP0401/0402-Restricted MAGE-A3-Reactive T Cell Receptor-transduced Autologous T Cells [NCIt concept]
- HPV 16 E6 (18-26) Peptide [NCIt concept]
- HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202 [NCIt concept]
- HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c [NCIt concept]
- HPV 16 E7:12-20 Peptide Vaccine [NCIt concept]
- HPV 16 E7:86-93 Peptide Vaccine [NCIt concept]
- HPV 16 L1-VLP [NCIt concept]
- HPV 16/18 E6/E7 DNA Vaccine pBI-11 [NCIt concept]
- HPV 18 E6:13-21 Peptide [NCIt concept]
- HPV E6/E7-encoding Semliki Forest Virus Vaccine Vvax001 [NCIt concept]
- HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C [NCIt concept]
- HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN [NCIt concept]
- HPV16 RG1 VLP Vaccine [NCIt concept]
- HPV16 Vaccine [NCIt concept]
- HSP90 Peptide Vaccine AST-021p [NCIt concept]
- Helicobacter pylori Therapeutic Vaccine IMX101 [NCIt concept]
- Hepatitis B Virus Antigen Peptides/Hepatitis G2 Cell Protein Lysate-activated Dendritic Cells [NCIt concept]
- Hsp70-peptide TKD/IL-2-activated Autologous Natural Killer Cells [NCIt concept]
- Human Anti-CD30 CAR-expressing Autologous T-lymphocytes [NCIt concept]
- Human Papillomavirus 16 E7 Peptide/Padre 965.10 [NCIt concept]
- ICT-121 Dendritic Cell Vaccine [NCIt concept]
- IDH1R132H Mutation-targeting IDH1 Peptide Vaccine [NCIt concept]
- IDH1R132H-Specific Peptide Vaccine PEPIDH1M [NCIt concept]
- IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells [NCIt concept]
- IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes [NCIt concept]
- IMT-1012 Immunotherapeutic Vaccine [NCIt concept]
- Idecabtagene Vicleucel [NCIt concept]
- Imsapepimut [NCIt concept]
- Inaticabtagene Autoleucel [NCIt concept]
- Indoleamine 2,3-dioxygenase Peptide Vaccine [NCIt concept]
- Itezocabtagene Autoleucel [NCIt concept]
- K-RAS ASP-12 Mutant Protein [NCIt concept]
- K-RAS ASP-13 Mutant Protein [NCIt concept]
- K-RAS GLY-12 Mutant Protein [NCIt concept]
- K-RAS VAL-12 Mutant Protein [NCIt concept]
- KLH-Lymphoma Ig Vaccine [NCIt concept]
- KRAS CYS-12 Mutant Protein [NCIt concept]
- LMP-2:340-349 Peptide Vaccine [NCIt concept]
- LMP-2:419-427 Peptide Vaccine [NCIt concept]
- LMP2-specific T Cell Receptor-transduced Autologous T-lymphocytes [NCIt concept]
- LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine [NCIt concept]
- Labyrinthin Peptide Vaccine LabVax 3(22)-23 [NCIt concept]
- Latromotide [NCIt concept]
- Letetresgene Autoleucel [NCIt concept]
- Lifileucel [NCIt concept]
- Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101 [NCIt concept]
- Liposomal MUC1/PET-lipid A Vaccine ONT-10 [NCIt concept]
- Lisocabtagene Maraleucel [NCIt concept]
- Long PD-L1 Peptide Vaccine [NCIt concept]
- Long Peptide Vaccine 7 [NCIt concept]
- Lovotibeglogene Autotemcel [NCIt concept]
- Lymphodepleted Autologous CD4-directed CAR T Cells [NCIt concept]
- MAGE-12: 170-178 Peptide [NCIt concept]
- MAGE-3 Peptide Vaccine [NCIt concept]
- MAGE-3.A1 Peptide Vaccine [NCIt concept]
- MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells [NCIt concept]
- MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine [NCIt concept]
- MAGE-A3 Peptide Vaccine [NCIt concept]
- MAGE-A3 Reactive T Cell Receptor-transduced Autologous T Cells [NCIt concept]
- MAGE-A3/12-specific TCR Gene-transduced Autologous PBLs [NCIt concept]
- MAGE-A3/HPV 16 Peptide Vaccine [NCIt concept]
- MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201 [NCIt concept]
- MART-1 Reactive CD8+ T-lymphocytes [NCIt concept]
- MART-1:26-35(27L) Peptide Vaccine [NCIt concept]
- MART-1:27-35 Peptide Vaccine [NCIt concept]
- MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells [NCIt concept]
- MDS Neoantigen-specific Autologous T-lymphocytes [NCIt concept]
- MELITAC 12.1 Peptide Vaccine [NCIt concept]
- MF59 Adjuvanted Molecular Clamp Stabilized SARS-CoV-2 Spike Protein Vaccine [NCIt concept]
- MSCV (MGMTP140K) Retroviral Vector-Transduced CD34+ Autologous PBSC [NCIt concept]
- MUC-1 Peptide Vaccine [NCIt concept]
- MUC-1/WT1 Peptide-primed Autologous Dendritic Cells [NCIt concept]
- MUC1 Antigen/SB AS-2 [NCIt concept]
- MUC1 SP Vaccine [NCIt concept]
- MUC1-KLH Vaccine/QS21 [NCIt concept]
- MUC1-targeted Peptide GO-203-2C [NCIt concept]
- MVA-BN Smallpox Vaccine [NCIt concept]
- MVF-HER-2(597-626)/MVF-HER-2 (266-296) Peptide Vaccine [NCIt concept]
- Manufactured Autologous Anti-BCMA CAR-T Cells [NCIt concept]
- Maveropepimut-S [NCIt concept]
- Melan-A VLP Vaccine [NCIt concept]
- Melan-A/MAGE-3.DP4 Peptide Vaccine [NCIt concept]
- Melanoma Tumor-Reactive Autologous Tumor Infiltrating Lymphocyte [NCIt concept]
- Microbiome-derived Peptide Vaccine EO2040 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO2401 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO2463 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO4010 [NCIt concept]
- Mifamurtide [NCIt concept]
- Mimotope-P10s-PADRE Peptide Vaccine [NCIt concept]
- Mipetresgene Autoleucel [NCIt concept]
- Montanide ISA-51/Survivin Peptide Vaccine [NCIt concept]
- Multi-antigen-directed Autologous T-cells NEXI-002 [NCIt concept]
- Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200 [NCIt concept]
- Multi-epitope Folate Receptor Alpha Peptide Vaccine [NCIt concept]
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine [NCIt concept]
- Multi-epitope HER2 Peptide Vaccine H2NVAC [NCIt concept]
- Multi-epitope HER2 Peptide Vaccine TPIV100 [NCIt concept]
- Multi-peptide CMV-Modified Vaccinia Ankara Vaccine [NCIt concept]
- Multipeptide Vaccine S-588210 [NCIt concept]
- Multiple TAA-loaded Dendritic Cell Vaccine [NCIt concept]
- Mutated Ras Peptide [NCIt concept]
- Myeloma Ig Id-KLH Conjugate Vaccine [NCIt concept]
- NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine [NCIt concept]
- NA17.A2 Peptide Vaccine [NCIt concept]
- NGFR-transduced Autologous T Lymphocytes [NCIt concept]
- NSCLC-specific Marrow Infiltrating Lymphocytes [NCIt concept]
- NY-ESO-1 Peptide Vaccine [NCIt concept]
- NY-ESO-1 Peptides/Threitolceramide-6-loaded Nanoparticles PORT-3 [NCIt concept]
- NY-ESO-1 Protein/Microparticle MDP/Bacterial DNA-containing MIS416 Vaccine [NCIt concept]
- NY-ESO-1 Reactive TCR Retroviral Vector Transduced Autologous PBL [NCIt concept]
- NY-ESO-1/LAGE-1 Peptide Vaccine [NCIt concept]
- NY-ESO-1/MAGE-A4/PRAME/Survivin/SSX2-specific Autologous Cytotoxic T Lymphocytes [NCIt concept]
- NY-ESO-1/PRAME/MAGE-A3/WT-1 Peptide Vaccine [NCIt concept]
- NY-ESO-1b Peptide Vaccine [NCIt concept]
- NY-ESO-B [NCIt concept]
- Neldaleucel [NCIt concept]
- Nelipepimut-S Plus GM-CSF Vaccine [NCIt concept]
- Neo-multiple TAA-loaded Dendritic Cell Vaccine [NCIt concept]
- Neoantigen Vaccine GEN-009 [NCIt concept]
- Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017 [NCIt concept]
- Neoantigen-based Glioblastoma Vaccine [NCIt concept]
- Obecabtagene Autoleucel [NCIt concept]
- Olitresgene Autoleucel [NCIt concept]
- Onilcamotide [NCIt concept]
- Orvacabtagene Autoleucel [NCIt concept]
- Osencabtagene Autoleucel [NCIt concept]
- Ovapuldencel-T [NCIt concept]
- Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine [NCIt concept]
- P30-linked EphA2/CMV pp65/Survivin Peptide Vaccine P30-EPS [NCIt concept]
- P53-Synthetic Long Peptides Vaccine [NCIt concept]
- PADRE-CMV Fusion Peptide Vaccine [NCIt concept]
- PAX3/FKHR Peptide Vaccine [NCIt concept]
- PCLUS 3-18MN [NCIt concept]
- PCLUS 6.1-18MN [NCIt concept]
- PD-1-positive B-cell Peptide Antigen/MVF IMU-201/Montanide Vaccine [NCIt concept]
- PD-L1 Peptide Vaccine [NCIt concept]
- PD-L1/IDO Peptide Vaccine IO102-103 [NCIt concept]
- PD-L1/PD-L2 Peptide-Montanide Vaccine [NCIt concept]
- PD-L2 Peptide-Montanide Vaccine [NCIt concept]
- PDCD-1 Knockout Autologous T-lymphocytes [NCIt concept]
- PEP-CMV Vaccine [NCIt concept]
- PG13/LNc8 Retroviral Transduced Cloned T-Cells [NCIt concept]
- PR-151 Peptide [NCIt concept]
- PR-54 (ras-13 Asp) Peptide [NCIt concept]
- PR-5V10 (ras-12 Val) Peptide [NCIt concept]
- PR1 Leukemia Peptide Vaccine [NCIt concept]
- PR18 (ras-12CYS) Peptide [NCIt concept]
- PR18 (ras-13 Cys) Peptide [NCIt concept]
- PR6V10 (ras-12 Asp) Peptide [NCIt concept]
- PR7V10 (ras-12 Ala) Peptide [NCIt concept]
- PSA-OP Peptide Vaccine [NCIt concept]
- PSA:154-163 Peptide [NCIt concept]
- PSA:154-163(155L) Peptide Vaccine [NCIt concept]
- PSMA/TARP Peptide Vaccine [NCIt concept]
- Patient-derived WT1/PRAME/Survivin-specific Cytotoxic T-lymphocytes [NCIt concept]
- Peptide Vaccine [NCIt concept]
- Personalized ALL-specific Multi-HLA-binding Peptide Vaccine [NCIt concept]
- Personalized Liposomal Neoantigen-based Peptide Vaccine EVX-01 [NCIt concept]
- Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01 [NCIt concept]
- Personalized Neoantigen-specific T-lymphocytes NEO-PTC-01 [NCIt concept]
- Personalized Peptides-loaded Autologous Dendritic Cell Vaccine [NCIt concept]
- Personalized Synthetic Long Peptide Vaccine [NCIt concept]
- Plixacabtagene Autoleucel [NCIt concept]
- Pomlucabtagene Autoleucel [NCIt concept]
- Pooled Mutant KRAS-Targeted Long Peptide Vaccine [NCIt concept]
- Pradimotide [NCIt concept]
- Prizloncabtagene Autoleucel [NCIt concept]
- Prodencel [NCIt concept]
- Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024 [NCIt concept]
- Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine [NCIt concept]
- RAS Peptide Cancer Vaccine [NCIt concept]
- RAS Peptide Cancer Vaccine TG01 [NCIt concept]
- RNA Electroporated CD19CAR-CD3zeta-4-1BB-expressing Autologous T-lymphocytes [NCIt concept]
- ROR1 CAR-specific Autologous T-Lymphocytes [NCIt concept]
- Rapamycin-Polarized Th1/Tc1 Autologous T Lymphocytes [NCIt concept]
- Rapcabtagene Autoleucel [NCIt concept]
- Ras Peptide ASP [NCIt concept]
- Ras Peptide CYS [NCIt concept]
- Ras Peptide VAL [NCIt concept]
- Recombinant 2019-nCoV S Protein Subunit-trimer Vaccine SCB-2019 [NCIt concept]
- Recombinant Anti-WT1 Immunotherapeutic GSK2302024A [NCIt concept]
- Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine [NCIt concept]
- Recombinant Spike-protein Receptor-binding Domain-dimer SARS-CoV-2 Vaccine [NCIt concept]
- Recombinant Vaccinia DF3/MUC1 Vaccine [NCIt concept]
- Recombinant Vaccinia-MUC1-B7 Vaccine [NCIt concept]
- Recombinant dHER2 Vaccine [NCIt concept]
- Relmacabtagene Autoleucel [NCIt concept]
- Renal Cell Carcinoma Peptides Vaccine IMA901 [NCIt concept]
- Renal Tumor-Reactive Autologous Peripheral Blood Lymphocyte [NCIt concept]
- Renal Tumor-Reactive Autologous Tumor Infiltrating Lymphocyte [NCIt concept]
- Ribrecabtagene Autoleucel [NCIt concept]
- Riletamotide [NCIt concept]
- Rovaleucel [NCIt concept]
- SARS-CoV-2 Protein Subunit Vaccine AKS-452 [NCIt concept]
- SARS-CoV-2 rS Nanoparticle Vaccine NVX-CoV2373 [NCIt concept]
- SBIL-2 Transduced Autologous Tumor-Infiltrating Lymphocyte [NCIt concept]
- SVN53-67/M57-KLH Peptide Vaccine [NCIt concept]
- Satricabtagene Autoleucel [NCIt concept]
- Sipuleucel-T [NCIt concept]
- Stapuldencel-T [NCIt concept]
- Survivin Sur1M2 Peptide Vaccine [NCIt concept]
- Suvutresgene Autoleucel [NCIt concept]
- Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine [NCIt concept]
- Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2 [NCIt concept]
- Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1 [NCIt concept]
- Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201 [NCIt concept]
- Synthetic Long E6/E7 Peptides Vaccine HPV-01 [NCIt concept]
- Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b [NCIt concept]
- Synthetic Melanoma-Associated Antigens Vaccine [NCIt concept]
- Synthetic Peptides E-PRA And E-PSM Vaccine [NCIt concept]
- T1E28z CAR-expressing Autologous CD4-positive T Lymphocytes [NCIt concept]
- TARP 27-35 Peptide Vaccine [NCIt concept]
- TARP 29-37-9V Peptide Vaccine [NCIt concept]
- TCR-specific, alpha Fetoprotein-enhanced Autologous T Lymphocytes [NCIt concept]
- TGF-beta-15 Peptide Vaccine [NCIt concept]
- TGFbDNRII-transduced Autologous Tumor Infiltrating Lymphocytes [NCIt concept]
- TIL 1383I T Cell Receptor-Transduced Autologous T Cells [NCIt concept]
- TM4SF1-CAR/EpCAM-CAR-expressing Autologous T Cells [NCIt concept]
- TNF Transduced TIL [NCIt concept]
- TRP-2: 180-188 Peptide [NCIt concept]
- TRP1(0RF3):1-9 Peptide [NCIt concept]
- Tabelecleucel [NCIt concept]
- Tacatresgene Autoleucel [NCIt concept]
- Tapderimotide [NCIt concept]
- Tebrocabtagene Autoleucel [NCIt concept]
- Telomerase: 540-548 Peptide Vaccine [NCIt concept]
- Tertomotide [NCIt concept]
- Tetanus-CMV Fusion Peptide Vaccine [NCIt concept]
- Therapeutic Autologous Dendritic Cells [NCIt concept]
- Therapeutic Autologous Lymphocytes [NCIt concept]
- Therapeutic Cancer Vaccine ATP128 [NCIt concept]
- Therapeutic Cancer Vaccine ATP150 [NCIt concept]
- Therapeutic Cancer Vaccine ATP152 [NCIt concept]
- Therapeutic Ex-vivo-treated Autologous Central Memory T Cells [NCIt concept]
- Therapeutic Invariant Natural Killer T-cells [NCIt concept]
- Therapeutic Liver Cancer Peptide Vaccine IMA970A [NCIt concept]
- Therapeutic Tumor Infiltrating Lymphocytes [NCIt concept]
- Therapeutic gamma delta T-lymphocytes [NCIt concept]
- Tinocabtagene Autoleucel [NCIt concept]
- Tisagenlecleucel [NCIt concept]
- Total Tumor mRNA-pulsed Tumor-specific Ex vivo-expanded Autologous Lymphocyte Transfer Cells [NCIt concept]
- Trempamotide [NCIt concept]
- Trovocabtagene Autoleucel [NCIt concept]
- Type-1 Polarized Dendritic Cell-induced Antigen-specific Autologous Cytotoxic T Lymphocytes [NCIt concept]
- Tyrosinase Peptide [NCIt concept]
- Tyrosinase:146-156 Peptide [NCIt concept]
- Tyrosinase:206-214 Peptide [NCIt concept]
- Tyrosinase:240-251(244S) Peptide [NCIt concept]
- Tyrosinase:368-376(370D) Peptide [NCIt concept]
- URLC10 Peptide Vaccine [NCIt concept]
- URLC10-CDCA1-KOC1 Multipeptide Vaccine [NCIt concept]
- URLC10-TTK-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine [NCIt concept]
- UV1 Telomerase Peptide Vaccine [NCIt concept]
- Unconjugated Myeloma Ig Id [NCIt concept]
- Uzatresgene Autoleucel [NCIt concept]
- VEGFR1-1084 Peptide Vaccine [NCIt concept]
- VHL-42: 65-76(V74G) Peptide [NCIt concept]
- VHL-59: 116-128 Peptide [NCIt concept]
- VHL14 Peptide [NCIt concept]
- VHL16 Peptide [NCIt concept]
- VHL2 (Y12M) Peptide [NCIt concept]
- Vadacabtagene Leraleucel [NCIt concept]
- Vanutide Cridificar [NCIt concept]
- Varnimcabtagene Autoleucel [NCIt concept]
- Verpasep Caltespen [NCIt concept]
- Vibapapogene Autoleucel [NCIt concept]
- Von Hippel-Lindau Peptide Vaccine [NCIt concept]
- WT1 124-138 Peptide Vaccine [NCIt concept]
- WT1 126-134 Peptide Vaccine [NCIt concept]
- WT1 235-243 Peptide Vaccine [NCIt concept]
- WT1 247-261 Peptide Vaccine [NCIt concept]
- WT1 Analog Peptide Vaccine [NCIt concept]
- WT1 Peptide Vaccine OCV-501 [NCIt concept]
- WT1 Peptide Vaccine WT2725 [NCIt concept]
- WT1 Protein-derived Peptide Vaccine DSP-7888 [NCIt concept]
- WT1-A10/AS01B Immunotherapeutic GSK2130579A [NCIt concept]
- WT1-H/K-HELP-survivin-H/K-HELP-MAGE-A4-H / K-HELP-MUC1-22 Peptide-loaded Autologous Dendritic Cells [NCIt concept]
- Welgenaleucel [NCIt concept]
- XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410 [NCIt concept]
- Young Autologous Tumor-infiltrating Lymphocytes [NCIt concept]
- Zamtocabtagene Autoleucel [NCIt concept]
- Zevorcabtagene Autoleucel [NCIt concept]
- cMet CAR-mRNA Electroporated Autologous T Lymphocytes [NCIt concept]
- dHER2 Vaccine+AS15 Adjuvant [NCIt concept]
- gp100 Peptide-sensitized Autologous T-cells (CD4+ and CD8+) [NCIt concept]
- gp100 Protein (184V) [NCIt concept]
- gp100-Pulsed Peripheral Blood Mononuclear Cell [NCIt concept]
- gp100-Reactive Autologous Peripheral Blood Lymphocyte [NCIt concept]
- gp100-Reactive Autologous Tumor Infiltrating Lymphocyte [NCIt concept]
- gp100: ES209-217(210M) Peptide [NCIt concept]
- gp100:154-162 Peptide Vaccine [NCIt concept]
- gp100:17-25 Peptide [NCIt concept]
- gp100:209-217 Peptide [NCIt concept]
- gp100:209-217(210M) Peptide Vaccine [NCIt concept]
- gp100:280-288 Peptide Vaccine [NCIt concept]
- gp100:280-288(288V) Peptide Vaccine [NCIt concept]
- gp100:614-622 Peptide [NCIt concept]
- hTERT I540/R572Y/D988Y Multipeptide Vaccine [NCIt concept]
- hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301 [NCIt concept]
- hTERT Vaccine V934/V935 [NCIt concept]
- hTERT/Survivin/CMV Multipeptide Vaccine [NCIt concept]
- hVEGF26-104/RFASE Peptide Vaccine [NCIt concept]
- iC9-GD2-CAR-CD28-OX40-expressing Autologous NKT Cells [NCIt concept]
- mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902 [NCIt concept]
- p53 Peptide Vaccine MPS-128 [NCIt concept]
- pBCAR3 Phosphopeptide-tetanus Peptide Vaccine [NCIt concept]
- pBCAR3/pIRS2-Phosphopeptide-tetanus Peptide Vaccine [NCIt concept]
- pIRS2 Phosphopeptide-tetanus Peptide Vaccine [NCIt concept]
- rF-MUC1(DF3)/TRICOM Vaccine [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients